 |
 |
AstraZeneca settles Crestor lawsuit with Egis and Actavis
25 March 2013
|
|
|
|
AstraZeneca to eliminate 1,600 jobs in major R&D restructuring
19 March 2013
|
|
|
AstraZeneca chief hints at changes with adverse outlook as patents expire
02 February 2013
|
| | |
|
|
AstraZeneca loses appeal on lung cancer drug rights in India
28 November 2012
|
|
|
AstraZeneca to pay Bristol-Myers Squibb $135 mn more for Amylin drug rights
10 August 2012
|
|
|
Bristol-Myers Squibb, AstraZeneca expand alliance through Amylin acquisition
30 June 2012
|
|
|
AstraZeneca Q1 profit slumps; CEO quits
27 April 2012
|
|
|
AstraZeneca eliminates 7,300 jobs in major restructuring
03 February 2012
|
|
|
AstraZeneca to buy China’s generic maker Guangdong BeiKang Pharma
08 December 2011
|
|
|
AstraZeneca to cut 1,150 sales jobs in the US
08 December 2011
|
|
|
AstraZeneca - Bristol-Myers to present new data on diabetes drug
27 October 2011
|
|
|
AstraZeneca close to selling dental implants unit to Dentsply for $1.8 billion: report
21 June 2011
|
|
|
Russia, China precede India for AstraZeneca's expansion plans
18 June 2011
|
|
|
AstraZeneca to pay $250,000 to 124 women for sex discrimination
07 June 2011
|
|
|
AstraZeneca, Daiichi Sankyo to promote Amgen's new bone cancer drug
24 May 2011
|
|
|
AstraZeneca saves over $1 billion in tax dispute settlement
28 March 2011
|
|
|
AstraZeneca to pay $198 million to settle 17,500 Seroquel lawsuits
09 August 2010
|
|
|
AstraZeneca scrip slumps after buy-back offer
07 July 2010
|
|
|
AstraZeneca settles US drug pricing suit for $103 million
19 June 2010
|
|
|
AstraZeneca settles Seroquel case with US government for $520 million
28 April 2010
|
|
|
AstraZeneca, Bristol-Myers Squibb in diabetes research alliance
01 April 2010
|
|
|
Torrent in AstraZeneca's debut deal to sell branded generics
11 March 2010
|
|
|
AstraZeneca settles UK tax dispute with £505 million payout
24 February 2010
|
|
|
AstraZeneca India to pay 500 per cent dividend
23 February 2010
|
|
|
AstraZeneca inks arthritis drug deal with Rigel
16 February 2010
|
|
|
US FDA approves AstraZeneca's Crestor
09 February 2010
|
|
|
AstraZeneca reports profit, cuts 8,000 jobs to cut costs
29 January 2010
|
|
|
AstraZeneca settles another Nexium patent litigation for US sales
07 January 2010
|
|
|
AstraZeneca to acquire Novexel for $350 million, expand alliance with Forest Labs
24 December 2009
|
|
|
AstraZeneca says its new anti-clotting drug better than Plavix
31 August 2009
|
|
|
AstraZeneca, Merck & Co to in phase 1 cancer drug research
01 June 2009
|
|
|
Jubilant signs research deal with Anglo-Swedish firm AstraZeneca
06 May 2009
|
|
|
Infosys wins multi-million dollar AstraZeneca deal
15 December 2008
|
|
|
AstraZeneca, Abraxis rethink cancer drug deal
26 November 2008
|
|
|
AstraZeneca agrees to cut drug prices in UK, stock plummets
20 November 2008
|
|
|
Fish oil better than AstraZeneca's Crestor says new heart-failure study
01 September 2008
|
|
|
US court ruling helps AstraZeneca stave off Teva, Sandoz from 4$-billion Seroquel
03 July 2008
|
|
|
Ranbaxy settles litigation with AstraZeneca; to sell Nexium in US
15 April 2008
|
|
|
AstraZeneca forms clinical research venture with private equity firms
18 February 2008
|
|
|
AstraZeneca
acquires paediatric asthma development programmes from Verus Pharmaceuticals
25 September 2007
|
|
|
AstraZeneca
to acquire US biotech firm MedImmune for $15.6 billion
28 April 2007
|
|
|
Global collaboration to develop new anti-obesity compounds
02 February 2007
|
|
|
Nicholas Piramal India Limited signs 10-year manufacturing and supply agreement
24 November 2005
|
|
|
AstraZeneca sues Ranbaxy on Nexium patent
22 November 2005
|
|
|
AstraZeneca to drop Viozan
29 June 2001
|
|
|
AstraZeneca launches $ 100 million facility in China
30 April 2001
|
|
|
AstraZeneca to acquire development rights from Cyclacel
17 April 2001
|
|
|
AstraZeneca sells off speciality chemicals
13 May 1999
|
|
|
Cheminor unfazed by AstraZeneca
patent infringement suit
13 May 1999
|
